Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
5(26%)
Results Posted
17%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_4
6
32%
Ph phase_1
1
5%
Ph phase_2
3
16%
Ph phase_3
6
32%
Ph not_applicable
3
16%

Phase Distribution

1

Early Stage

3

Mid Stage

12

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
1(5.3%)
Phase 2Efficacy & side effects
3(15.8%)
Phase 3Large-scale testing
6(31.6%)
Phase 4Post-market surveillance
6(31.6%)
N/ANon-phased studies
3(15.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

5

trials recruiting

Total Trials

19

all time

Status Distribution
Active(7)
Completed(6)
Terminated(1)
Other(5)

Detailed Status

Completed6
unknown5
Recruiting4
Not yet recruiting2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
5
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.3%)
Phase 23 (15.8%)
Phase 36 (31.6%)
Phase 46 (31.6%)
N/A3 (15.8%)

Trials by Status

unknown526%
active_not_recruiting15%
completed632%
not_yet_recruiting211%
terminated15%
recruiting421%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT04184921Phase 2

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Completed
NCT05257824Phase 4

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Completed
NCT07275749Phase 3

Acetyl-leucine in Post-stroke Ataxia

Recruiting
NCT06580223Phase 3

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Not Yet Recruiting
NCT02804815Phase 3

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Active Not Recruiting
NCT06952712Phase 3

Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women

Not Yet Recruiting
NCT04069156Not Applicable

The ARIES HeartMate 3 Pump IDE Study

Completed
NCT05906199Phase 4

A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.

Completed
NCT04214990Phase 3

Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

Recruiting
NCT06417411Phase 1

LEARNER- Low dosE AspiRiN prEterm tRial (Angola)

Recruiting
NCT04128956Phase 2

Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS

Terminated
NCT05960721Not Applicable

Low-dose NOAC Versus GDMT After LAAO

Recruiting
NCT05554822Phase 3

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study

Unknown
NCT04260828Phase 4

Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Recipients

Unknown
NCT04256525Phase 4

Prophylactic Anticoagulation for Catheter-related Thrombosis

Unknown
NCT04365309Phase 2

Protective Effect of Aspirin on COVID-19 Patients

Unknown
NCT04051567Phase 4

Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies

Unknown
NCT01779401Not Applicable

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

Completed
NCT01830491Phase 4

Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19